HLTH Executive Series: Holistic Health Solutions with Dr. Carolyn Jasik, Omada Health
Holistic support, including lifestyle changes, is essential for weight management and diabetes, as GLP-1 medications are only one part of the solution.
In this episode, Dr. Carolyn Jasik, the Chief Medical Officer of Omada Health, discusses their approach to GLP-1s, emphasizing the importance of wraparound support, including mental health and physical therapy, as well as addressing concerns like muscle loss and the sustainability of weight loss. She highlights that the goal for many people is not to be on these medications forever and that an important element to consider is the rebound physiology that could drive people to regain weight after stopping treatment. Dr. Jasik also shares Omada's perspective on AI, explaining how it assists providers with clinical decision support based on their vast member history but doesn't replace the human connection needed for empathetic care.
Tune in and learn how Omada is leveraging AI to create a more personalized and effective healthcare experience that also focuses on long-term sustainability!
About Dr. Carolyn Jasik:
Carolyn is a board-certified physician with a background in health technology startups, multidisciplinary care, education, and research. As Chief Medical Officer at Omada, she uses her diverse expertise to improve user experience and introduce integrated healthcare solutions. Before joining Omada, Carolyn spent 14 years at the University of California as an Associate Professor of Pediatrics and Clinical Instructor at San Francisco General Hospital. She also served as Vice President of Medical Outcomes at Mango Health, a digital health startup. Carolyn earned a Bachelor's in Public Policy from Princeton University, a Medical Degree from the University of Chicago's Pritzker School of Medicine, and completed her research training at the University of California, San Francisco. She is board-certified in clinical informatics, adolescent medicine, and pediatrics. At Omada, Carolyn supports clinical and research teams, contributing to the development of innovative healthcare solutions.
Things You’ll Learn:
GLP-1 medications require comprehensive wraparound support, including lifestyle changes, mental health, and physical therapy, for effective and sustainable outcomes. The speed of weight loss, rather than the GLP-1 itself, is often the primary driver of muscle mass reduction.
Many individuals on GLP-1s aim to eventually discontinue the medication, making long-term lifestyle planning a crucial part of the treatment.
Stopping GLP-1s abruptly can trigger rebound weight gain due to the body's natural metabolic response.
AI's role in healthcare should be focused on enhancing human care delivery, not replacing the crucial empathetic connection.
The future of healthcare will include advanced primary care that addresses the gaps between traditional doctor visits.
Resources:
